BACE1 and early-onset autosomal dominant Alzheimer disease: Additionally, we conducted ADME (Absorption, Distribution, Metabolism, and Excretion) and toxicity (T) analyses of the selected top dual inhibitors to find dual inhibitors of AChE and BACE1 for developing lead compounds with fewer side effects and more potency against Alzheimer’s disease.